Biophytis SA logo

ALBPS - Biophytis SA Share Price

€1.19 -0.0  -3.6%

Last Trade - 4:38pm

Small Cap
Market Cap £58.3m
Enterprise Value £57.3m
Revenue £n/a
Position in Universe 582nd / 847
Unlock ALBPS Revenue
Relative Strength (%)
1m -17.8%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -54.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 119
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Biophytis SArevenues was not reported. Net loss decreased 7% toEUR9.5M. Lower net loss reflects Fair Value of Derivatives- Gain/Loss increase from EUR0K to EUR2.3M (income), OtherOperating Expense decrease of 56% to EUR1.5M (expense),Personnel Expense in S&G decrease of 41% to EUR743K(expense). Basic Earnings per Share excluding ExtraordinaryItems increased from -EUR0.76 to -EUR0.25.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ALBPS Revenue Unlock ALBPS Revenue

Net Income

ALBPS Net Income Unlock ALBPS Revenue

Normalised EPS

ALBPS Normalised EPS Unlock ALBPS Revenue

PE Ratio Range

ALBPS PE Ratio Range Unlock ALBPS Revenue

Dividend Yield Range

ALBPS Dividend Yield Range Unlock ALBPS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ALBPS EPS Forecasts Unlock ALBPS Revenue
Profile Summary

Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated April 20, 2007
Public Since July 13, 2015
No. of Shareholders: n/a
No. of Employees: 21
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Euronext - Paris
Shares in Issue 54,834,978
Free Float (0.0%)
Eligible for
ALBPS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ALBPS
Upcoming Events for ALBPS
Monday 10th May, 2021
Biophytis SA Extraordinary Shareholders Meeting
Frequently Asked Questions for Biophytis SA
What is the Biophytis SA share price?

As of 4:38pm, shares in Biophytis SA are trading at €1.19, giving the company a market capitalisation of £58.3m. This share price information is delayed by 15 minutes.

How has the Biophytis SA share price performed this year?

Shares in Biophytis SA are currently trading at €1.19 and the price has moved by 0.414k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biophytis SA price has moved by 0.364k% over the past year.

What are the analyst and broker recommendations for Biophytis SA?

Of the analysts with advisory recommendations for Biophytis SA, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Biophytis SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Biophytis SA next release its financial results?

Biophytis SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Biophytis SA dividend yield?

Biophytis SA does not currently pay a dividend.

Does Biophytis SA pay a dividend?

Biophytis SA does not currently pay a dividend.

When does Biophytis SA next pay dividends?

Biophytis SA does not currently pay a dividend.

How do I buy Biophytis SA shares?

To buy shares in Biophytis SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biophytis SA?

Shares in Biophytis SA are currently trading at €1.19, giving the company a market capitalisation of £58.3m.

Where are Biophytis SA shares listed? Where are Biophytis SA shares listed?

Here are the trading details for Biophytis SA:

Country of listing: France
Exchange: PAR
Ticker Symbol: ALBPS
What kind of share is Biophytis SA?

Based on an overall assessment of its quality, value and momentum, Biophytis SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Biophytis SA share price forecast 2021?

Shares in Biophytis SA are currently priced at €1.19. At that level they are trading at 13.45% discount to the analyst consensus target price of 0.00.

Analysts covering Biophytis SA currently have a consensus Earnings Per Share (EPS) forecast of -0.22 for the next financial year.

How can I tell whether the Biophytis SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biophytis SA. Over the past six months, the relative strength of its shares against the market has been 0.116k%. At the current price of €1.19, shares in Biophytis SA are trading at 53.93% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biophytis SA PE Ratio?

We were not able to find PE ratio data for Biophytis SA.

Who are the key directors of Biophytis SA?

Biophytis SA's management team is headed by:

Stanislas Veillet - CHM
Waly Dioh - COO
Micheline Kergoat - DRC
Nadine Coulm - IND
Pierre Dilda - CSO
Eric Rowinsky - DRC
Dimitri Batsis - DRC
Jean Franchi - DRC
Manfred Horst - VBD
Philippe Dupont - VPR
Samuel Agus - OTH
Evelyne Nguyen - CFO
Who are the major shareholders of Biophytis SA?

Here are the top five shareholders of Biophytis SA based on the size of their shareholding:

Veillet (Stanislas) Individual Investor
Percentage owned: 2.78% (3.15m shares)
Biophytis SA Management Corporation
Percentage owned: 0.76% (862k shares)
Pacific Select International Small-Cap Portfolio Mutual Fund
Percentage owned: 0.44% (500k shares)
QS Investors, LLC Investment Advisor/Hedge Fund
Percentage owned: 0.44% (500k shares)
Dioh (Waly Ph.D.) Individual Investor
Percentage owned: 0.12% (136k shares)
Similar to ALBPS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.